Toxina Botulínica e o processamento das emoções: uma revisão de literatura sobre os efeitos além da pele
DOI:
https://doi.org/10.34119/bjhrv6n3-378Keywords:
autoestima, depressão, feedback facial, toxina BotulínicaAbstract
A toxina botulínica do tipo A é o tratamento estético não cirúrgico mais comum em todo o mundo. Seu mecanismo de ação consiste em bloquear a liberação da acetilcolina, neurotransmissor responsável pelas contrações musculares, reduzindo, assim, o aparecimento das rítides causadas pela hiperatividade dos músculos, o que gera um resultado estético relevante. No entanto, há evidências de que esse procedimento não é somente uma forma de amenizar as rugas. A toxina botulínica também pode interferir na propriocepção das emoções, de acordo com a teoria do feedback facial, e trazer efeitos emocionais na vida do paciente, haja vista que a musculatura facial não só expressa, mas também pode regular as emoções. O objetivo deste trabalho foi mostrar que o tratamento com esse neuromodulador traz consequências que vão além da estética na vida do paciente, melhorando sua autoestima e também podendo atenuar os sintomas de ansiedade e depressão. Sendo assim, seus resultados geram um impacto positivo na qualidade de vida.
References
Molina N, Grangier Y, Mole B, Ribe N, Diaz LM, Prager W, et al. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study. J Eur Acad Dermatol Venereol 2015;29(7):1382-1388.
Fossaic R, Benatar MJ. Influence of Botulinum Toxin Type A Esthetic Injections on Facial Expressions. J Cosmet Dermatol 2021;20(5);1405-1410.
Rosen R, Stewart T. Results of a 10-year follow-up study of botulinum toxin A therapy for primary axillary hyperhidrosis in Australia. Intern Med J 2018;48(3);343-347.
Dong H, Fan S, Luo Y, Peng B. Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm. Neuropsychiatr Dis Treat 2019;15:33-36.
Baumeister JC, Papa G, Foroni F. Deeper than skin deep – The effect of botulinum toxin-A on emotion processing. Toxicon 2016;118:86-90.
Finzi E, Rosenthal NE. Emotional proprioception: Treatment of depression with afferent facial feedback. J Psychiatr Res 2016;80:93-96.
Schulze J, Neumann I, Magid M, Finzi E, Sinke C, Wollmer MA, et al. Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis. J Psychiatr Res 2021;135:332-340.
Cristel RT, Gandhi ND, Issa TZ, Kola E, Demesh D, Dayan SH. A Randomized, Single-Blind, Crossover Study Evaluating the Impact of OnabotulinumtoxinA Treatment on Mood and Appearance During the COVID-19 Pandemic. Aesthet Surg J 2021;41(9):1199-1205.
Wollmer MA, Magid M, Kruger THC, Finzi E. Treatment of Depression with Botulinum Toxin. Hand Exp Phamacol 2021;263:265-278.
Sykianakis D, Stratigos A, Chatziioannou A, Christodoulou C. Botulinum toxin type A treatment is associated with improveed social and psychological behavior: A retrospective study. J Cosmet Dermatol 2022;21(1):142-148.
Scharschmidt D, Mirastschijski U, Preiss S, Brähler E, Fischer T, Borkenhagen A. Body Image, Personality Traits, and Quality of Life in Botulinum Toxin A and Dermal Filler Patients. Aesthetic Plast Surg 2018;42(4):1119-1125.
Dayan SH, Arkins JP, Patel AB, Gal TJ. A Double-Blind, Randomized, Placebo-Controlled Health-Outcomes Survey of the Effect of Botulinum Toxin Type A Injections on Quality of Life and Self-Esteem. Dermatol Surg 2010;36(4):2088-2097.
Dayan SH, Lieberman ED, Thakkar NN, Larimer KA, Anstead A. Botulinum Toxin a Can Positively Impact First Impression. Dermatol Surg 2008;34(1):40-47.
Petrie T, Moore F. Facial Treatment with Botulinum Toxin Improves Attractiveness Rated by Self and Others and Psychological Wellbeing. Dermatol Surg, 2017;43(3):322-328.
Dobel C, Algermissen E, Thielker J, Geibler K, Volk GF, Klingner C, et al. Rating of Emotional Expressions in Static and Dynamic Facial Recordings Before and After Upper Face Botulinum Injections — An Observational Prospective Study. Aesthet Surg J 2021;41(6):609-615.
Ekman P. Facial Expression and Emotion. Am Psychol 1993;48(4):384-392.
Nestor MS, Fischer DL, Arnold D. "Masking" our emotions: Botulinum toxin, facial expression, and well-being in the age of COVID-19. J Cosmet Dermatol 2020;19(9):2154-2160.
Dimberg U, Thunberg M. Empathy, emotional contagion, and rapid facial reactions to angry and happy facial expression. Psych J 2012;1(2):118-127.
Bulnes LC, Mariën P, Vandekerckhove M, Cleeremans A. The effects of Botulinum toxin on the detection of gradual changes in facial emotion. Sci Rep 2019;9(1):11734-11746.
Kruger THC, Schulze J, Bechinie A, Neumann I, Jung S, Sperling C, et al. Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder. Sci Rep 2022;12(1)14197.
Hennenlotter A, Dresel C, Castrop F, Ceballos-Baumann AO, Wohlschläger AM, Haslinger B. The link between facial feedback and neural activity within central circuitries of emotion – new insights of botulinum toxin – induced denervation of frown muscles. Cereb Cortex 2008;19(3):537-542.
Kim MJ, Neta M, Davis FC, Ruberry EJ, Dinescu D, Heatherton TF, et al. Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design. Biol Mood Anxiety Disord. 2014;4:11.
Strack F, Martin LL, Stepper S. Inhibiting and facilitating conditions of the human smile: a nonobtrusive test of the facial feedback hypothesis. J Pers Soc Psychol 1988;54(5):768-777.
Larsen RJ, Kasimatis M, Frey K. Facilitating the Furrowed Brow: An Unobtrusive Test of the Facial Feedback Hypothesis Applied to Unpleasant Affect. Cong Emot 1992;6(5):321-338.
Alam M, Barrett KC, Hodapp RM, Arndt KA. Botulinum Toxin and the facial feedback hypothesis: Can looking better make you feel happier? J Am Acad Dermatol 2008;58(6):1061-1072.
Lewis MB, Bowler PJ. Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol 2009;8(1):24-26.
Wollmer MA, Magid M, Kruger THC, Finzi E. The use of botulinum toxin in treatment of depression. Toxins 2022;14(6):383-392.
Lewis MB. Exploring the positive and negative implications of facial feedback. Emotion. 2012;12(4):852-959
Han C, Park G, Wang S, Can botulim toxin improve mood in depressed patients?. Expert Rev. Neurother 2012;12(9):1049-1051.
Miligen LBA, Verhoeven JE, Schmaal L, van Velzen LS, Révész D, Black CN, et al. The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study. BMC psychiatry 2019;19(1):425-435.
Hexsel D, Brum C, Siega C, Schilling-Souza J, Dal'Forno T, Heckmann M, et al. Evaluation of Self-Esteem and Depression Symptoms in Depressed and Nondepressed Subjects Treated with Onabotulinumtoxin A for Glabelar Lines. Dermatol Surg 2013;39(7):1088-1096.
Zhang Q, Wu W, Fan Y, Li Y, Liu J, Xu Y, et al. The safety and efficacy of botulinum toxin A on the treatment of depression. Brain Behav 2021;11(9):2333-2343.
Khademi M, Roohaninasab M, Goodarzi A, Seirafianpour F, Dodangeh M, Khademi A. The healing effects of facial Botox injection on symptoms of depression alongside its effects on beauty preservation. J Cosmetic Dermatol 2021;20(5):1411-1415.
Finzi E, Wasserman E. Treatment of Depression with Botulinum Toxin A: A Case Series. Dermatol Surg 2006;32(5):645-650.
Wolmer MA, Boer C, Kalak N, Beck J, Götz T, Schmidt T, et al. Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res 2012;46(5):574-581.
Chugh S, Chhabria A, Jung S, Kruger THC, Wollmer MA. Botulim Toxin as a Treatment for Depression in a Real-world Setting. J Psychiatr Pract 2018;24(1):15-20.
Zhu C, Wang K, Yu T, Liu H. Effects of botulinum toxin type a on mood and cognitive function in patients with parkinson’s disease and depression. Am J Transl Res 2021;13(4):2717-2723.
Wollmer MA, Makunts T, Kruger THC, Abagyan R. Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety. Sci Rep 2021;11(1):24173-24180.
Costa ACF, da Siva EC, Gondim DV. Botulim Toxin in Facial Aesthetics Affects Emotion Process: A Meta-analysis of Randomized Controlled Trials. Clin Psychopharmacol and Neurosci 2022;20(4):600-608.
Rudorfer MV. Botulinum Toxin: Does it have a Place in Management of Depression? CNS Drugs 2018;32(2):97-100.
Li Y, Liu J, Liu X, Su C, Zhang Q, Wang Z, et al. Antidepressant-Like Action of Single Facial Injection of Botulinum Neurotoxin A is Associated with Augmented 5-HT Levels and BDNF/ERK/CREB Pathways in Mouse Brain. Neurosci Bull 2019;35(4):661-672.
Finzi E. Update: Botulinum Toxin for Depression: More Than Skin Deep. Dermatol Surg 2018;44(10):1363-1365.
Patel S. OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females. 2017. Avaiable from: https://clinicaltrials.gov/ct2/show/study/NCT02116361. Acess 7 Apr 2023.
